Current approaches for immediately loading dental implants rely upon clinical trials and evidence-based practice. Despite their wide utility, these studies have limited predictability because they ignore a whole set of parameters, mainly the environmental parameters that have increasingly influenced the bone biological response. Bone is a very dynamic tissue and its reaction to surgical and functional implant procedures is variable; therefore, bone remodeling must be a key factor in any clinical decision, and a need for reliable tests to evaluate this process is an eventual challenge to implant success. New advances in medicine based upon individual genomic, proteomic and metabolomic studies incorporate the impact of environmental elements, permitting a better targeting of implant therapy. Previously, we proposed a new clinical concept of implant therapy based on personalized bone turnover. Here, we elaborate on current tests and future "omics" biotechnologies to assess the turnover process, hence, providing a realistic approach to individual evaluations of bone remodeling.
|Original language||English (US)|
|Number of pages||3|
|Journal||The New York state dental journal|
|State||Published - Jun 2010|
ASJC Scopus subject areas